Related Experiment Video
Updated: Jun 3, 2026
11:00
Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
Published on: December 16, 2016
Reprogramming of mouse and human somatic cells by high-performance engineered factors
Yang Wang1, Jiekai Chen, Jia-Lei Hu
1The State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue-Yang Road, Shanghai 200031, China.
EMBO Reports
|March 15, 2011
Summary
Scientists engineered synthetic factors to improve induced pluripotent stem cell (iPSC) generation. These novel factors, including Oct4-VP16, enhance reprogramming efficiency and speed, offering a potential paradigm shift in regenerative medicine.
Area of Science:
- Cell Biology
- Stem Cell Research
- Molecular Biology
Background:
- Induced pluripotent stem cells (iPSCs) offer regenerative potential but current reprogramming methods are inefficient.
- Understanding the molecular mechanisms of somatic cell reprogramming is crucial for therapeutic applications.
Purpose of the Study:
- To engineer novel synthetic reprogramming factors with enhanced potency.
- To investigate the efficiency and kinetics of these synthetic factors in reprogramming somatic cells.
- To explore the role of transcriptional reactivation in somatic cell to iPSC conversion.
Main Methods:
- Fusion of the VP16 transactivation domain to key reprogramming factors (OCT4, NANOG, SOX2).
- Delivery of synthetic factors via episomal vectors for integration-free iPSC generation.
- Reprogramming of mouse and human fibroblasts and mouse embryonic fibroblasts (MEFs).
Main Results:
- Synthetic factors significantly enhanced reprogramming efficiency and kinetics in both mouse and human cells.
- Oct4-VP16 alone demonstrated high efficiency in reprogramming MEFs into germline-competent iPSCs.
- Episomal delivery of synthetic factors yielded integration-free iPSCs with improved efficiency.
Conclusions:
- Engineering synthetic reprogramming factors is a viable strategy to overcome current limitations.
- Transcriptional reactivation of OCT4 target genes may be a rate-limiting step in reprogramming.
- Synthetic factor-based reprogramming represents a promising advancement for future regenerative medicine applications.
More Related Videos
Related Concept Videos
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:24Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
01:32Chromatin Modification in iPS Cells
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
01:14Introduction to Nuclear Reprogramming
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
01:28Forced Transdifferentiation
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Artificial transdifferentiation occurs...
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.